Literature DB >> 23539676

State of the Art Review: Colorectal Cancer Screening.

Joseph A Diaz1, Teresa Slomka.   

Abstract

Although colorectal cancer is the third leading cause of cancer-related deaths in the U.S., the burden of this disease could be dramatically reduced by increased utilization of screening. Evidence-based recommendations and guidelines from national societies recommend screening all average risk adults starting at age fifty. However, the myriad of screening options and slight differences in screening recommendations between guidelines may lead to confusion among patients and their primary care providers. This goal of this review is to briefly summarize the colorectal cancer screening guidelines issued by three major organizations, compare their recommendations, and address emerging issues in colorectal cancer screening.

Entities:  

Keywords:  Colorectal Cancer; Recommendation/Guidelines; Screening

Year:  2011        PMID: 23539676      PMCID: PMC3607450          DOI: 10.1177/1559827611413243

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  47 in total

1.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

Authors:  Perry J Pickhardt; J Richard Choi; Inku Hwang; James A Butler; Michael L Puckett; Hans A Hildebrandt; Roy K Wong; Pamela A Nugent; Pauline A Mysliwiec; William R Schindler
Journal:  N Engl J Med       Date:  2003-12-01       Impact factor: 91.245

2.  National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.

Authors:  Donald Steinwachs; Jennifer Dacey Allen; William Eric Barlow; R Paul Duncan; Leonard E Egede; Lawrence S Friedman; Nancy L Keating; Paula Kim; Judith R Lave; Thomas A Laveist; Roberta B Ness; Robert J Optican; Beth A Virnig
Journal:  Ann Intern Med       Date:  2010-04-13       Impact factor: 25.391

3.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; John L Petrini; Todd H Baron; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; Klaus Mergener; Bret T Petersen; Michael A Safdi; Douglas O Faigel; Irving M Pike
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

4.  Screening for nonpolypoid colorectal neoplasms.

Authors:  Perry J Pickhardt; Bernard Levin; John H Bond
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

5.  A national survey of primary care physicians' methods for screening for fecal occult blood.

Authors:  Marion R Nadel; Jean A Shapiro; Carrie N Klabunde; Laura C Seeff; Robert Uhler; Robert A Smith; David F Ransohoff
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

8.  Effect of language on colorectal cancer screening among Latinos and non-Latinos.

Authors:  Joseph A Diaz; Mary B Roberts; Roberta E Goldman; Sherrie Weitzen; Charles B Eaton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

9.  Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Authors:  David A Ahlquist; Daniel J Sargent; Charles L Loprinzi; Theodore R Levin; Douglas K Rex; Dennis J Ahnen; Kandice Knigge; M Peter Lance; Lawrence J Burgart; Stanley R Hamilton; James E Allison; Michael J Lawson; Mary E Devens; Jonathan J Harrington; Shauna L Hillman
Journal:  Ann Intern Med       Date:  2008-10-07       Impact factor: 25.391

10.  Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Authors:  Ann G Zauber; Iris Lansdorp-Vogelaar; Amy B Knudsen; Janneke Wilschut; Marjolein van Ballegooijen; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

View more
  3 in total

Review 1.  Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.

Authors:  Ganepola Ap Ganepola; Joel Nizin; John R Rutledge; David H Chang
Journal:  World J Gastrointest Oncol       Date:  2014-04-15

2.  The impact of supplementary narrative-based information on colorectal cancer screening beliefs and intention.

Authors:  Lesley M McGregor; Christian von Wagner; Gemma Vart; Wing Chee Yuen; Rosalind Raine; Jane Wardle; Kathryn A Robb
Journal:  BMC Cancer       Date:  2015-03-21       Impact factor: 4.430

3.  Immunochemical fecal occult blood test for detection of advanced colonic adenomas and colorectal cancer: comparison with colonoscopy results.

Authors:  Bianca Rosa Viana Freitas; Cristiane Kibune Nagasako; Celia Regina Pavan; Sônia Letícia Silva Lorena; Fabio Guerrazzi; Cláudio Saddy Rodrigues Coy; Maria de Lourdes S Ayrizono; Maria Aparecida Mesquita
Journal:  Gastroenterol Res Pract       Date:  2013-11-11       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.